Up 11.5%+ this month, is this Dow giant a buy ahead of tomorrow’s earnings?
Markets remain on edge as tariff tensions stir fresh uncertainty. While headlines have traders glued to macro risks, a few individual names are quietly defying the trend—and one healthcare heavyweight is stealing the spotlight just ahead of earnings.